Clinical significance of miR-6515-5p in predicting diagnosis and prognosis for acute respiratory distress syndrome suffering from pulmonary fibrosis

Table 1 Baseline data of subjects

characteristics	Healthy controls (n = 88)	ARDS patients (n = 210)	P-value
Age (years)	53.57 ± 7.13	52.87 ± 8.23	0.489
Sex (male/female)	47/41	101/109	0.403
BMI (kg/m²)	23.56 ± 3.71	24.64 ± 3.61	0.090
Smoking (no/yes)	41/47	94/116	0.772
WBC (×10⁹/L)	-	13.19 ± 4.39	-
CRP (mg/L)	-	50.86 ± 25.16	-
PCT (ng/mL)	-	1.08 ± 0.73	-
TNF-α (pg/mL)	-	24.09 ± 12.87	-
IL-1β (pg/mL)	-	20.62 ± 7.32	-
IL-6 (pg/mL)	-	98.83 ± 58.85	-
FVC (%)	-	81.19 ± 13.94	-
DLCO (%)	-	62.01 ± 14.08	-
Murray score	-	2.35 ± 1.07	-
APACHE II score	-	15.97 ± 5.99	-

Note: ARDS, acute respiratory distress syndrome; PLF, pulmonary fibrosis; WBC, white blood cells; CRP, c-reactive protein; PCT, procalcitonin; TNF-α, tumor necrosis factor-α; IL, interleukin; FVC, forced vital capacity; DLCO, diffusion lung CO; -, no data

ISSN: 1601-5223